Intracellular ribozyme applications

被引:18
作者
Castanotto, D
Li, JR
Michienzi, A
Langlois, MA
Lee, NS
Puymirat, J
Rossi, JJ [1 ]
机构
[1] Beckman Res Inst City Hope, Div Mol Biol, Duarte, CA 91010 USA
[2] Univ Laval, Med Res Ctr, Lab Human Genet, CHUQ, Ste Foy, PQ G1V 7P4, Canada
关键词
cancer; functional genomics; genetic disease; HIV; nucleolus;
D O I
10.1042/BST0301140
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The exquisite target selectivity of trans-acting ribozymes has fostered their use as potential therapeutic agents and tools for down-regulating cellular transcripts. In living cells, free diffusion of RNAs is extremely limited, if it exists at all. Thus, getting ribozymes to base-pair with their cognate targets requires co-localizing the ribozyme transcript with the target RNA. In addition, not all sites along a given target RNA are equally accessible to ribozyme base pairing. Cellular proteins greatly influence the trafficking and structure of RNA, and therefore making ribozymes work effectively in cells a significant challenge. This article addresses the problems of getting engineered ribozymes to effectively pair with and cleave targets in cells. The work described here illuminates methods for target-site selection on native mRNAs, methods for ribozyme expression, and strategies for obtaining a discrete intracellular localization of ribozymes.
引用
收藏
页码:1140 / 1145
页数:6
相关论文
共 29 条
[1]
Bertrand E, 1997, RNA, V3, P75
[2]
Reduction of histone cytotoxicity by the Alzheimer beta-amyloid peptide precursor [J].
Currie, JR ;
ChenHwang, MC ;
Denman, R ;
Smedman, M ;
Potempska, A ;
Ramakrishna, N ;
Rubenstein, R ;
Wisniewski, HM ;
Miller, DL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1997, 1355 (03) :248-258
[3]
CZUBAYKO F, 1994, J BIOL CHEM, V269, P21358
[4]
Adenovirus-mediated transduction of ribozymes abrogates HER-2/neu and pleiotrophin expression and inhibits tumor cell proliferation [J].
Czubayko, F ;
Downing, SG ;
Hsieh, SS ;
Goldstein, DJ ;
Lu, PY ;
Trapnell, BC ;
Wellstein, A .
GENE THERAPY, 1997, 4 (09) :943-949
[5]
Self-cleaving-ribozyme-mediated reduction of βAPP in human rhabdomyosarcoma cells [J].
Dolzhanskaya, N ;
Conti, J ;
Schwenk, V ;
Merz, G ;
Denman, RB .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 387 (02) :223-232
[6]
RIBOZYME-MEDIATED ATTENUATION OF PANCREATIC BETA-CELL GLUCOKINASE EXPRESSION IN TRANSGENIC MICE RESULTS IN IMPAIRED GLUCOSE-INDUCED INSULIN-SECRETION [J].
EFRAT, S ;
LEISER, M ;
WU, YJ ;
FUSCODEMANE, D ;
EMRAN, OA ;
SURANA, M ;
JETTON, TL ;
MAGNUSON, MA ;
WEIR, G ;
FLEISCHER, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2051-2055
[7]
FUNATO T, 1992, ADV ENZYME REGUL, V32, P195
[8]
Gibson SA, 2000, CLIN CANCER RES, V6, P213
[9]
Expression of small, therapeutic RNAs in human cell nuclei [J].
Good, PD ;
Krikos, AJ ;
Li, SXL ;
Bertrand, E ;
Lee, NS ;
Giver, L ;
Ellington, A ;
Zaia, JA ;
Rossi, JJ ;
Engelke, DR .
GENE THERAPY, 1997, 4 (01) :45-54
[10]
THE RNA MOIETY OF RIBONUCLEASE-P IS THE CATALYTIC SUBUNIT OF THE ENZYME [J].
GUERRIERTAKADA, C ;
GARDINER, K ;
MARSH, T ;
PACE, N ;
ALTMAN, S .
CELL, 1983, 35 (03) :849-857